Volume 21 Issue 5
May  2023
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2023  >  21(5): 833-837
ZHU Ling, PAN Xuekui, WANG Huifeng, MEI Lina. Value of the competing risk model including sonographically estimated mid-gestation fetal weight in predicting pre-eclampsia risk[J]. Chinese Journal of General Practice, 2023, 21(5): 833-837. doi: 10.16766/j.cnki.issn.1674-4152.002995
Citation: ZHU Ling, PAN Xuekui, WANG Huifeng, MEI Lina. Value of the competing risk model including sonographically estimated mid-gestation fetal weight in predicting pre-eclampsia risk[J]. Chinese Journal of General Practice, 2023, 21(5): 833-837. doi: 10.16766/j.cnki.issn.1674-4152.002995
shu

Value of the competing risk model including sonographically estimated mid-gestation fetal weight in predicting pre-eclampsia risk

doi: 10.16766/j.cnki.issn.1674-4152.002995

  • Department of Ultrasound, Huzhou Maternity and Child Health Care Hospital, Huzhou, Zhejiang 313000, China

Funds:

 2022KY1226

  • Received Date: 2022-02-23
    Abstract
  •   Objective  To develop a competing risk model using sonographically estimated mid-gestation fetal weight for predicting pre-eclampsia risk, and to assess the effectiveness of the model.  Methods  A total of 2 234 women from 19+0 to 24+6 weeks of gestation who underwent routine antenatal checks at Huzhou Maternity and Child Health Care Hospital from March 2019 to December 2020 were selected for this study. Demographic characteristics and medical history were recorded, and fetal weight and hemodynamic parameters were estimated by sonography. The incidence of pre-eclampsia was determined by a follow-up till delivery. General data were compared between women with and without pre-eclampsia matched in a 1∶1 ratio using propensity score matching. A competing risk model was used to screen independent risk factors for pre-eclampsia, and the identified risk factors were used to construct a competing risk model for pre-eclampsia, and the predictive performance of the model was analyzed.  Results  Of the 2 234 cases, 63 were lost to follow-up and the remaining 2 171 were finally included, including 86 with pre-eclampsia (pre-eclampsia group). Sixty pairs were successfully matched. Multivariate competing risk analysis showed that the risk of pre-eclampsia was significantly increased in pregnant women with high mean arterial pressure (MAP), peripheral vascular resistance (PVR) and mean uterine artery pulsatility index (UtA-PI, SHR=1.150, 1.102 and 1.168, all P < 0.05), whereas the risk was significantly lower in those with high fetal weight estimated using sonography (SHR=0.110, P < 0.05). The nomogram constructed using risk factors identified by competing-risks regression obtained a C-index of 0.785 in predicting the risk of pre-eclampsia, showing a high concordance between prediction and reality.  Conclusion  High MAP, PVR and UtA-PI are risk factors for pre-eclampsia, whereas high fetal weight at mid-gestation stage estimated by sonography is a protective factor for pre-eclampsia. The competing risk model for predicting the risk of pre-eclampsia by including the four aforementioned factors has a high predictive value and clinical practicality, which will facilitate screening for pre-eclampsia in high-risk groups.

     

    • FullText(HTML)
  • loading
    • References(22)
  • [1]
    吕英, 叶丽燕, 范徐妃, 等. 子痫前期P53和LncRNA TINCR表达及胎盘滋养层细胞凋亡研究[J]. 中华全科医学, 2021, 19(4): 611-613. doi: 10.16766/j.cnki.issn.1674-4152.001874

    LV Y, YE L Y, FAN X F, et al. Expression of P53 and LncRNA TINCR and apoptosis of placental trophoblast cells in preeclampsia[J]. Chinese Journal of General Practice, 2021, 19(4): 611-613. doi: 10.16766/j.cnki.issn.1674-4152.001874
    [2]
    顾蔚蓉, 李笑天. 子痫前期的干预与管理[J]. 中国实用妇科与产科杂志, 2020, 36(2): 120-123. doi: 10.19538/j.fk2020020108

    GU W R, LI X T Intervention and management of preeclampsia[J]. Chinese Journal of Practical Gynecology and Obstetrics, 2020, 36(2): 120-123. doi: 10.19538/j.fk2020020108
    [3]
    SERRA B, MENDOZA M, SCAZZOCCHIO E, et al. A new model for screening for early-onset preeclampsia[J]. Am J Obstet Gynecol, 2020, 222(6): 608. e1-608. e18. DOI: 10.1016/j.ajog.2020.01.020.
    [4]
    BARTSCH E, MEDCALF K E, PARK A L, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies[J]. BMJ, 2016, 353: i1753. DOI: 10.1136/bmj.i1753.
    [5]
    PEDROSO M A, PALMER K R, HODGES R J, et al. Uterine artery doppler in screening for preeclampsia and fetal growth restriction[J]. Rev Bras Ginecol Obstet, 2018, 40(5): 287-293. doi: 10.1055/s-0038-1660777
    [6]
    MARASCIULO F, ORABONA R, FRATELLI N, et al. Preeclampsia and late fetal growth restriction[J]. Minerva Obstet Gynecol, 2021, 73(4): 435-441.
    [7]
    FARAH O, NGUYEN C, TEKKATTE C, et al. Trophoblast lineage-specific differentiation and associated alterations in preeclampsia and fetal growth restriction[J]. Placenta, 2020, 102(1): 4-9.
    [8]
    HADLOCK F P, HARRIST R B, SHARMAN R S, et al. Estimation of fetal weight with the use of head, body, and femur measurements: a prospective study[J]. Am J Obstet Gynecol, 1985, 151(3): 333-337. doi: 10.1016/0002-9378(85)90298-4
    [9]
    中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2015)[J]. 中华妇产科杂志, 2015, 50(10): 721-728. doi: 10.3760/cma.j.issn.0529-567x.2015.10.001

    Pregnancy-induced hypertension Disease Group, Chinese Society of Obstetrics and Gynecology. Guidelines for Diagnosis and Treatment of Hypertensive Diseases during Pregnancy (2015)[J]. Chinese Journal of Obstetrics and Gynecology, 2015, 50(10): 721-728. doi: 10.3760/cma.j.issn.0529-567x.2015.10.001
    [10]
    严檬洁, 谷茂红, 徐友娣. 热休克蛋白70与重度子痫前期的临床研究[J]. 中华全科医学, 2021, 19(11): 1884-1887. doi: 10.16766/j.cnki.issn.1674-4152.002192

    YAN M J, GU M H, XU Y D. Clinical study on heat shock protein 70 and severe preeclampsia[J]. Chinese Journal of General Practice, 2021, 19(11): 1884-1887. doi: 10.16766/j.cnki.issn.1674-4152.002192
    [11]
    ROBERGE S, BUJOLD E, NICOLAIDES K H. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis[J]. Am J Obstet Gynecol, 2018, 218(3): 287-293. e1. doi: 10.1016/j.ajog.2017.11.561
    [12]
    ZOTOVA T Y, BLAGONRAVOV M L, LAPAEV N N, et al. Hemodynamic allostasis of pregnant women against the background of preeclampsia[J]. Bull Exp Biol Med, 2018, 165(4): 440-444. doi: 10.1007/s10517-018-4189-4
    [13]
    PHOPPS E A, THADHANI R, BENZING T, et al. Author correction: pre-eclampsia: pathogenesis, novel diagnostics and therapies[J]. Nat Rev Nephrol, 2019, 15(6): 386. doi: 10.1038/s41581-019-0156-1
    [14]
    SOTIRIADIS A, ELEFTHERIADES M, PAPADOPDULOS V, et al. Divergence of estimated fetal weight and birth weight in singleton fetuses[J]. J Matern Fetal Neonatal Med, 2018, 31(6): 761-769. doi: 10.1080/14767058.2017.1297409
    [15]
    TOMIMATSU T, MIMURA K, MATSUZAKI S, et al. Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors[J]. Int J Mol Sci, 2019, 20(17): 42-46.
    [16]
    CHAU K, HENNESSY A, MAKRIS A. Placental growth factor and pre-eclampsia[J]. J Hum Hypertens, 2017, 31(12): 782-786. doi: 10.1038/jhh.2017.61
    [17]
    DUHIG K E, MYERS J, SEED P T, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial[J]. Lancet, 2019, 393(10183): 1807-1818. doi: 10.1016/S0140-6736(18)33212-4
    [18]
    DUHIG K E, SEED P T, MYERS J E, et al. Placental growth factor testing for suspected pre-eclampsia: a cost-effectiveness analysis[J]. BJOG, 2019, 126(11): 1390-1398.
    [19]
    WEBSTER L M, CONTI-RAMSDEN F, SEED P T, et al. Impact of antihypertensive treatment on maternal and perinatal outcomes in pregnancy complicated by chronic hypertension: a systematic review and meta-analysis[J]. J Am Heart Assoc, 2017, 6(5): e005526. DOI: 10.1161/JAHA.117.005526.
    [20]
    SANTOS S, VOERMAN E, AMIANO P, et al. Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts[J]. BJOG, 2019, 126(8): 984-995.
    [21]
    LITWINSKA M, LITWINSKA E, LISNERE K, et al. Stratification of pregnancy care based on risk of pre-eclampsia derived from uterine artery Doppler at 19-24 weeks' gestation[J]. Ultrasound Obstet Gynecol, 2021, 58(1): 67-76.
    [22]
    FREI L, WRIGHT A, SYNGELAKI A, et al. Estimated fetal weight at mid-gestation in prediction of pre-eclampsia in singleton pregnancy [J]. Ultrasound Obstet Gynecol, 2022, 59(3): 335-341.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(3)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (204) PDF downloads(7) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return